Wells Fargo & Company Forecasts Strong Price Appreciation for Solventum (NYSE:SOLV) Stock

Key Points

• Wells Fargo has raised its target price for Solventum (NYSE:SOLV) from $79.00 to $82.00, indicating a potential upside of 11.69% from the stock's current price.
• Solventum's quarterly earnings surpassed expectations, with an EPS of $1.69, while revenue reached $2.16 billion, beating the consensus estimates.
• Four analysts currently rate Solventum as a Buy, with an average target price of $85.44, reflecting a mixed outlook among analysts.

Solventum (NYSE:SOLV - Free Report) had its price objective raised by Wells Fargo & Company from $79.00 to $82.00 in a research note released on Monday morning,Benzinga reports. Wells Fargo & Company currently has an equal weight rating on the stock.

Other research analysts have also recently issued reports about the stock. Wall Street Zen cut shares of Solventum from a "strong-buy" rating to a "buy" rating in a research report on Tuesday, September 9th. Argus raised shares of Solventum from a "hold" rating to a "buy" rating and set a $90.00 price target for the company in a research report on Tuesday, July 1st. KeyCorp assumed coverage on shares of Solventum in a research report on Friday, June 6th. They set a "sector weight" rating for the company. Jefferies Financial Group assumed coverage on shares of Solventum in a research report on Thursday, September 11th. They set a "hold" rating and a $80.00 price target for the company. Finally, Morgan Stanley raised shares of Solventum from an "equal weight" rating to an "overweight" rating and lifted their price target for the company from $80.00 to $103.00 in a research report on Tuesday, July 15th. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, Solventum presently has an average rating of "Hold" and an average target price of $85.44.

Solventum Trading Down 0.6%

Solventum stock traded down $0.41 during trading hours on Monday, reaching $73.96. The stock had a trading volume of 337,910 shares, compared to its average volume of 1,081,773. The stock has a market cap of $12.82 billion, a PE ratio of 34.24, a PEG ratio of 3.02 and a beta of 0.53. Solventum has a 52 week low of $60.70 and a 52 week high of $85.92. The company has a debt-to-equity ratio of 2.14, a current ratio of 1.22 and a quick ratio of 0.86. The company has a fifty day simple moving average of $72.98 and a 200-day simple moving average of $72.44.

Solventum (NYSE:SOLV - Get Free Report) last announced its earnings results on Thursday, August 7th. The company reported $1.69 earnings per share for the quarter, beating analysts' consensus estimates of $1.45 by $0.24. The firm had revenue of $2.16 billion for the quarter, compared to analyst estimates of $2.12 billion. Solventum had a net margin of 4.52% and a return on equity of 29.93%. The company's revenue for the quarter was up 3.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.56 EPS. Solventum has set its FY 2025 guidance at 5.800-5.950 EPS. Analysts forecast that Solventum will post 6.58 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. Rossby Financial LCC bought a new stake in Solventum during the first quarter valued at approximately $25,000. Strengthening Families & Communities LLC lifted its holdings in shares of Solventum by 376.8% in the first quarter. Strengthening Families & Communities LLC now owns 329 shares of the company's stock worth $25,000 after buying an additional 260 shares in the last quarter. CYBER HORNET ETFs LLC purchased a new stake in Solventum during the second quarter valued at $28,000. Raiffeisen Bank International AG purchased a new stake in Solventum during the fourth quarter valued at $29,000. Finally, Barrett & Company Inc. raised its stake in Solventum by 206.2% during the second quarter. Barrett & Company Inc. now owns 398 shares of the company's stock valued at $30,000 after purchasing an additional 268 shares in the last quarter.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.